Your browser doesn't support javascript.
loading
Dose Consideration of Lenvatinib's Anti-Cancer Effect on Hepatocellular Carcinoma and the Potential Benefit of Combined Colchicine Therapy.
Lin, Zu-Yau; Yeh, Ming-Lun; Liang, Po-Cheng; Hsu, Po-Yao; Huang, Chung-Feng; Huang, Jee-Fu; Dai, Chia-Yen; Yu, Ming-Lung; Chuang, Wan-Long.
Afiliação
  • Lin ZY; Division of Hepatobiliary Medicine, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung 80756, Taiwan.
  • Yeh ML; Department of Internal Medicine, Faculty of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 80708, Taiwan.
  • Liang PC; Center for Cancer Research, Kaohsiung Medical University, Kaohsiung 80708, Taiwan.
  • Hsu PY; Center for Liquid Biopsy and Cohort Research, Kaohsiung Medical University, Kaohsiung 80708, Taiwan.
  • Huang CF; Division of Hepatobiliary Medicine, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung 80756, Taiwan.
  • Huang JF; Department of Internal Medicine, Faculty of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 80708, Taiwan.
  • Dai CY; Center for Cancer Research, Kaohsiung Medical University, Kaohsiung 80708, Taiwan.
  • Yu ML; Center for Liquid Biopsy and Cohort Research, Kaohsiung Medical University, Kaohsiung 80708, Taiwan.
  • Chuang WL; Division of Hepatobiliary Medicine, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung 80756, Taiwan.
Cancers (Basel) ; 15(20)2023 Oct 22.
Article em En | MEDLINE | ID: mdl-37894463

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Cancers (Basel) Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Taiwan País de publicação: Suíça

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Cancers (Basel) Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Taiwan País de publicação: Suíça